News

🔹 Afrigen Biologics (Pty) Ltd is honoured to participate in the World Bio Summit in Seoul, South Korea, championing bio-innovation for a better world. 🔹 hashtag#afrigen hashtag#worldbiosummit hashtag#bioinnovation hashtag#betterworld

Click on the link to watch the video: https://lnkd.in/dVy3EypV 🔹 Dr. Caryn Fenner, Executive Director of the mRNA Hub, Afrigen Biologics (Pty) Ltd will be discussing about hashtag#mRNA technology platform

Afrigen proudly welcomes our colleagues from Institute Torlak, #mRNA Technology transfer programme Serbian partner, for 3- week intensive training as part of the technology transfer demonstration activities. This includes manufacturing drug

TO VIEW THE PDF, CLICK HERE: Preclinical evaluation in hamster model of the mRNA COVID-19 vaccine candidate AfriVac 2121 (Wuhan) produced under the WHO/MPP mRNA Technology Transfer Programme

Afrigen’s congratulates Bio-Sourcing on its fund-raising success and is excited to be a partner in bringing this innovative technology to Africa. Bio-Sourcing secures European Innovation Council (EIC) Accelerator funding to

27 Aug 2024; OSLO, Norway; CAPE TOWN, South Africa: Scientists in South Africa will investigate whether synthetic DNA could act as an alternative to traditional plasmid DNA required for mRNA vaccines—potentially

Read more

“Afrigen Biologics (Pty) Ltd proud to have contributed to advancing acces to hashtag#mRNA technology for pandemic preparedness and response in LMICs. We are looking forward to continuing working with our

Merck Inks Deal to Develop mRNA in Africa–Continent Prepares to Become Vaccine Development Independent. Merck KGaA or “Merck Germany” entered into a non-binding Memorandum of Understanding (MoU) with Afrigen Biologics

WHO Establishes First Vaccine Technology Transfer Hub In South Africa ⬇ https://lnkd.in/dCSjZpH6 #RNAgenetictechnology #mNRA #mNRAtechnology #biotechnology Pfizer-BioNTech Moderna Biovac World Health Organization Afrigen Biologics (Pty) Ltd